Brazilian research organization Hcor has successfully transformed its clinical trial operations by implementing Oracle Clinical One Data Collection to independently build and manage critical phase 3 immunology studies. The move represents a significant shift from the institute's previous reliance on third-party firms, enabling greater autonomy in trial management while reducing costs and accelerating execution timelines.
Independent Study Management Capabilities
Hcor, a Brazilian hospital specializing in cardiology, oncology, and other health areas, has leveraged Oracle's cloud-based data collection solution to build two important immunology trials independently. "Hcor is dedicated to delivering the best healthcare possible, and technology plays a crucial role in achieving that goal," said Tamiris Abait Miranda, research institute manager at Hcor. "With Oracle Clinical One Data Collection, we have built two important immunology trials independently using Oracle's robust and reliable platform, which can help to accelerate potentially life-changing clinical trials."
The platform's modern approach to electronic data capture enables life sciences organizations to collect datasets from diverse sources and unlock valuable clinical insights. Oracle was recognized as a leader in the latest Everest Group PEAK Matrix for electronic data capture, validating the platform's comprehensive capabilities.
Streamlined Trial Operations
Oracle Clinical One Data Collection's intuitive, user-friendly design allows organizations to execute study builds and make real-time, mid-study adjustments without sacrificing quality or requiring costly intervention from third-party vendors or programmers. This capability has proven essential for accelerating trial execution timelines and reducing study build times.
"Our unified platform helps organizations like Hcor make it easier to build studies independently and have more flexibility and control throughout the entire trial lifecycle," said Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences. "This is part of our larger mission to help our customers leverage the latest in AI and cloud technology to drastically change how studies are conducted."
Enhanced IT Performance and Development Speed
Beyond clinical trial management, Hcor has also implemented Oracle Exadata Cloud@Customer, which has delivered substantial operational improvements. The solution has boosted Hcor's overall IT performance by 20%, enabling the organization's developers to launch healthcare projects five times faster than before.
The performance enhancement has dramatically reduced development timelines, with Hcor now delivering fully tested applications in one month instead of the previous five-month timeframe. Additionally, the solution has significantly enhanced security and increased the number of projects that can be completed per month, reducing backlog and accelerating patient care initiatives.
Strategic Focus on Patient-Centric Solutions
Oracle's broader mission centers on helping customers leverage AI and cloud technology to transform study conduct through patient-centric solutions. The company aims to connect patients and trials at the point of care, enhance safety monitoring, accelerate data collection, and expedite regulatory submissions to bring life-changing therapies to patients more rapidly.
Built on the security, performance, and scalability of Oracle Cloud Infrastructure, Oracle Clinical One Data Collection is part of Oracle's comprehensive portfolio of life sciences solutions designed to address the evolving needs of clinical research organizations.
